We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$924M
AUM Growth
-$461K
Cap. Flow
-$13.7M
Cap. Flow %
-1.49%
Top 10 Hldgs %
30.49%
Holding
268
New
8
Increased
62
Reduced
122
Closed
10

Top Buys

Rank Stock Value
1
BKU icon
Bankunited
BKU
+$10.4M
2
GBDC icon
Golub Capital BDC
GBDC
+$4.16M
3
NEM icon
Newmont
NEM
+$631K
4
FLS icon
Flowserve
FLS
+$439K
5
EOG icon
EOG Resources
EOG
+$409K

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$3.34M
2
XOM icon
ExxonMobil
XOM
+$3.09M
3
EMC
EMC CORPORATION
EMC
+$2.46M
4
IBM icon
IBM
IBM
+$2.2M
5
TD icon
Toronto Dominion Bank
TD
+$1.56M

Sector Composition

Rank Sector Weight
1 Energy 20.32%
2 Industrials 19.18%
3 Healthcare 13.63%
4 Technology 11.77%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWW icon
126
W.W. Grainger
GWW
$60.2B
$756K 0.08%
2,992
+120
+4% +$29.9K
CSX icon
127
CSX Corp
CSX
$93.1B
$750K 0.08%
77,670
-2,400
-3% -$22.3K
BAX icon
128
Baxter International
BAX
$14.2B
$743K 0.08%
18,594
-3,728
-17% -$139K
DVY icon
129
iShares Select Dividend ETF
DVY
$23.6B
$728K 0.08%
9,929
-180
-2% -$12.8K
MMP
130
DELISTED
Magellan Midstream Partners, L.P.
MMP
$722K 0.08%
10,350
NVO
131
Novo Nordisk
NVO
$209B
$716K 0.08%
31,400
-156,850
-83% -$3.34M
MKC icon
132
McCormick & Company Non-Voting
MKC
$14.2B
$705K 0.08%
19,652
-3,348
-15% -$113K
CFR icon
133
Cullen/Frost Bankers
CFR
$10.2B
$700K 0.08%
9,029
CERN
134
DELISTED
Cerner Corp
CERN
$681K 0.07%
12,100
PSX icon
135
Phillips 66
PSX
$81.4B
$673K 0.07%
8,737
XLY icon
136
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$667K 0.07%
20,620
-340
-2% -$11.1K
ZBH icon
137
Zimmer Biomet
ZBH
$18.4B
$663K 0.07%
7,221
-942
-12% -$86.8K
ROK icon
138
Rockwell Automation
ROK
$49B
$623K 0.07%
4,999
+99
+2% +$11.8K
HES
139
DELISTED
Hess
HES
$610K 0.07%
7,360
APA icon
140
APA Corp
APA
$13.2B
$601K 0.07%
7,248
CNI icon
141
Canadian National Railway
CNI
$76.6B
$595K 0.06%
10,597
+770
+8% +$42.4K
VWO icon
142
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$585K 0.06%
14,413
+1,000
+7% +$38.8K
NI icon
143
NiSource
NI
$20.4B
$572K 0.06%
40,975
-5,344
-12% -$72.3K
C icon
144
Citigroup
C
$226B
$568K 0.06%
11,932
+1,575
+15% +$78.4K
GIS icon
145
General Mills
GIS
$19.7B
$568K 0.06%
10,964
-1,598
-13% -$79.1K
JCI icon
146
Johnson Controls International
JCI
$92.2B
$567K 0.06%
11,450
AMZN icon
147
Amazon
AMZN
$2.96T
$565K 0.06%
33,600
+1,000
+3% +$18.6K
ADM icon
148
Archer Daniels Midland
ADM
$36.9B
$564K 0.06%
13,001
PPL
149
PPL Corp
PPL
$26.7B
$528K 0.06%
17,120
-1,074
-6% -$31.2K
EQR icon
150
Equity Residential
EQR
$25.1B
$522K 0.06%
9,000

Similar funds

Neville Rodie & Shaw's Q1 2014 Portfolio in Review

As of Q1 2014, Neville Rodie & Shaw held 268 positions worth $924M, down 0.05% from $924M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Neville Rodie & Shaw's Q1 2014 filing shows 8 new, 62 increased, 122 reduced and 10 closed positions. Its largest new stake was Bankunited: 318,695 shares worth $11.1M. The largest sale was Novo Nordisk, an estimated $3.34M.

By sector, the portfolio is most concentrated in Energy at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Healthcare.

  • Neville Rodie & Shaw's largest Q1 2014 buy was Bankunited: 318,695 shares worth $11.1M.
  • Neville Rodie & Shaw added most to Golub Capital BDC in Q1 2014, an estimated $4.16M increase.
  • Neville Rodie & Shaw's biggest Q1 2014 reduction was Novo Nordisk, cutting an estimated $3.34M.
  • Neville Rodie & Shaw fully exited VanEck Oil Services ETF in Q1 2014, selling an estimated $1.21M.
  • Neville Rodie & Shaw's ten largest holdings make up 30% of its $924M portfolio in Q1 2014.
  • Neville Rodie & Shaw opened 8 new positions and closed 10 in Q1 2014.
  • Neville Rodie & Shaw's portfolio value fell 0.05% quarter-over-quarter to $924M.

Based on Neville Rodie & Shaw's 13F filing for Q1 2014, filed 8 Apr 2014.